Figure_2.tif (45.13 kB)
Survival rates of mice in each treatment group inoculated with 1×108 cfu V. vulnificus.
figure
posted on 2014-06-30, 03:00 authored by Hee-Chang Jang, Su-Mi Choi, Hee Kyung Kim, Sung-Eun Kim, Seung-Ji Kang, Kyung-Hwa Park, Phil Youl Ryu, Tae-Hoon Lee, Young Ran Kim, Joon Haeng Rhee, Sook-In Jung, Hyon E ChoyThe 96-h survival rate of the cefotaxime-plus-ciprofloxacin group (85%, 17/20) was significantly higher than that of the cefotaxime (0%, 0/20) or the cefotaxime-plus-minocycline groups (35%, 7/20) (P<0.001 and P = 0.003, respectively; log-rank test).
